Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session
$ACOR
$AGFY
$AKUS
$AUID
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Farming/Seeds/Milling
Consumer Staples
Gainers
- Akouos, Inc. (NASDAQ:AKUS) shares jumped 89.4% to $13.27. Eli Lilly And Co (NYSE:LLY) agreed to acquire Akouos for a 78% premium over Monday’s closing price of $7.01.
- Zovio Inc (NASDAQ:ZVO) rose 85.4% to $0.2674 after declining 11% on Monday.
- Helbiz, Inc. (NASDAQ:HLBZ) gained 82.2% to $0.4855. Helbiz CEO Salvatore Palella recently acquired a total of 200,000 shares at an average price of $0.25.
- COMSovereign Holding Corp. (NASDAQ:COMS) shares rose 55.4% to $0.0687 after gaining 4% on Monday.
- Eqonex Limited (NASDAQ:EQOS) gained 53.3% to $0.40.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares climbed 43.5% to $8.84. Kiora Pharmaceuticals, on Monday, announced publication of Phase 1 trial results for KIO-100 as a treatment for ocular inflammatory disease.
- AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) gained 40.7% to $14.75 after LG Chem announced it will acquire AVEO Oncology for $15 per share in cash.
- Bright Minds Biosciences Inc. (NASDAQ:DRUG) surged 40% to $1.3999.
- Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) gained 36% to $2.57 after the company announced plans to initiate a second clinical trial in Netherton Syndrome patients.
- Rubicon Technologies, Inc. (NYSE:RBT) jumped 32.7% to $1.46.
- Decibel Therapeutics, Inc. (NASDAQ:DBTX) rose 27.1% to $3.75. Decibel Therapeutics recently received FDA clearance of IND application for DB-OTO, a gene therapy product candidate designed to provide hearing to individuals with otoferlin-related hearing loss.
- Liquid Media Group Ltd. (NASDAQ:YVR) jumped 19.3% to $0.3581 after the company announced Q3 sales were up year over year.
- Ra Medical Systems, Inc. (NYSE:RMED) shares gained 17% to $6.37. Ra Medical Systems raised $7.6 million through completed at-the-market facility.
- IAMGOLD Corporation (NYSE:IAG) rose 15% to $1.2250 after the company announced an agreement to sell its interest in Rosebel Gold Mines to Zijin Mining for cash consideration of $360 million.
- Eterna Therapeutics Inc. (NASDAQ:ERNA) surged 13% to $5.60.
- NextPlay Technologies, Inc. (NASDAQ:NXTP) gained 10% to $0.2201. NextPlay Technologies recently announced its NextBank secured a $200,000,000 revolving credit line facility.
- Carnival Corporation (NYSE:CCL) rose 8.3% to $7.88 amid strength in cruise stocks. The company earlier announced a private offering of $1.25 billion aggregate principal amount of Senior Priority Notes due 2028.
- Tremor International Ltd (NASDAQ:TRMR) rose 7.1% to $7.71 after gaining 9% on Monday.
Losers
- Cosmos Holdings Inc. (NASDAQ:COSM) dropped 46% to $0.0805 after the company announced pricing of a $7.5 million upsized public offering at $0.12 per share.
- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares dipped 40.6% to $2.97 after the company announced a pause in new patient enrollment in its Phase 1/2 trial of seclidemstat in Ewing Sarcoma and FET-rearranged sarcomas following the death of a patient.
- Agrify Corporation (NASDAQ:AGFY) fell 39.4% to $6.48. Agrify said its Board of Directors approved a 1-for-10 reverse stock split.
- Inpixon (NASDAQ:INPX) fell 34.8% to $5.94. The company recently announced new purchase orders.
- Sierra Metals Inc. (NYSE:SMTS) dropped 32.6% to $0.33 after the company provided a financial and operations update and announced a strategic review process.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) dipped 25% to $1.6799. AVCT reported a $10 million registered direct offering and concurrent private placement priced at-the-market under Nasdaq rules.
- 9 Meters Biopharma, Inc. (NASDAQ:NMTR) fell 23% to $2.74. 9 Meters Biopharma announced a 1-for-20 reverse stock split.
- Venus Acquisition Corporation (NASDAQ:VENA) dropped 22.5% to $8.01.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares fell 22.3% to $0.6963. Acorda Therapeutics shares surged 164% on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
- Statera Biopharma, Inc. (NASDAQ:STAB) shares fell 22.2% to $0.1670 after jumping 35% on Monday. Statera Biopharma announced signing of a binding MOU with Holobeam Technologies to gain access to Holobeam's disruptive diagnostic imaging and therapeutic technology for cancer patients.
- Silvergate Capital Corporation (NYSE:SI) dropped 21% to $55.98 after the company reported worse-than-expected Q3 EPS and sales results.
- FLJ Group Limited (NASDAQ:FLJ) fell 20% to $1.57.
- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) fell 20% to $7.66 after jumping 26% on Monday.
- Xtant Medical Holdings, Inc. (NYSE:XTNT) dropped 17.7% to $0.6583.
- authID Inc. (NASDAQ:AUID) fell 14.6% to $1.41.
- Vigil Neuroscience, Inc. (NASDAQ:VIGL) dropped 11.8% to $13.26.
- Forge Global Holdings, Inc. (NASDAQ:FRGE) shares fell 7.8% to $1.6227 after gaining 21% on Monday.
- Nuwellis, Inc. (NASDAQ:NUWE) shares fell 7.3% to $0.2780 after surging 15% on Monday. Nuwellis recently announced pricing of $9.6 million upsized underwritten public offering.